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Estimating Severe 
Coccidioidomycosis 
in California 
Valerie J. Flaherman,* Richard Hector,*† 
and George W. Rutherford*†
We used hospital discharge data to estimate incidence 
and distribution of coccidioidomycosis-associated hospital-
izations in California. For 1997–2002, the average annual 
rate of hospitalization was 3.67 per 100,000 population. 
County of residence, older age, black race, male sex, HIV 
infection, and pregnancy were strongly associated with in-
creased risk for hospitalization.
Coccidioidomycosis is caused by the fungi Coccidi-oides immitis and C. posadasii, which are present in 
soil in disease-endemic areas. Data are sparse on frequency 
and incidence of severe coccidioidomycosis that requires 
hospitalization. In California, population increase, chang-
ing racial composition, and increasing numbers of immu-
nocompromised persons may have affected the incidence 
and severity of disease in recent years. We used hospital 
discharge data to estimate frequency and incidence of hos-
pitalization with coccidioidomycosis for California, includ-
ing its counties and its demographic subgroups.
The Study
We examined the Inpatient Hospital Discharge Data 
Set from the California Offi ce of Statewide Health Plan-
ning and Development for 1997–2002 (1), which contains 
inpatient discharge diagnoses from all nonfederal hospitals 
in California. We abstracted all records with any Interna-
tional Classifi cation of Diseases, 9th edition (ICD-9), code 
for coccidioidomycosis (114–114.5 and 114.9, with 114.2 
representing coccidioidal meningitis) and defi ned each re-
cord as a discrete hospitalization.
From each record, we extracted year of admission, coun-
ty of residence, age, race, ethnicity, sex, presence of HIV 
infection (ICD-9 codes 042 or V08), pregnancy status (ICD9 
codes V22-V23.9 or 630–676.9), vital status at discharge, 
and record locator number (RLN) (available for 1997–2000 
only). We obtained population estimates from California 
Department of Finance by county of residence, age, racial-
ethnic group, and sex (2,3). Numbers of AIDS cases and es-
timates of the population with HIV were obtained from the 
California Department of Health Services (4).
All statistical analysis was conducted by using Stata 
8.2 (Stata Corp., College Station, TX, USA). We calculat-
ed the frequency of hospitalization by county, age group, 
racial-ethnic group, sex, pregnancy status, and immune 
status. Incidence of initial hospitalization for severe coc-
cidioidomycosis was estimated by using each earliest hos-
pitalization with a given RLN during the years 1997–2000 
for which RLN was available, and rates of repeat hospital-
ization were calculated on the basis of subsequent hospital-
izations with the same RLN. Mortality rate was calculated 
as crude incidence rate for death among those hospitalized 
for coccidioidomycosis with unique RLNs.
Bivariate relative risks (RRs) were calculated for the 
effect of pregnancy status and immune status on the fre-
quency of hospitalization. Multivariate Poisson regression 
was used to estimate RR of year, county, age, racial-eth-
nic category, and sex on the frequency of hospitalization 
for coccidioidomcyosis. Among those hospitalized, multi-
variate logistic regression was used to evaluate odds ratios 
(ORs) for race, ethnicity, and sex on rehospitalization and 
meningitis.
Records for which data were missing for age, sex, 
race/ethnicity, or county were not included in multivariate 
analysis. Records that lacked data for county were not in-
cluded in crude incidence calculations by county. For crude 
incidence calculations by age, race/ethnicity, and sex, cases 
for which category was unknown were redistributed among 
known categories in the same proportion as they occurred 
among those with known category. This study was ap-
proved by the Committee on Human Research, University 
of California, San Francisco.
From 1997 through 2002, of 7,457 inpatient hospital-
izations associated with coccidioidomycosis in nonfederal 
institutions in California, 3,707 (50%) had a principal di-
agnosis of coccidioidomycosis, 1,605 (22%) had a fi rst ad-
ditional diagnosis of coccidioidomycosis, and 896 (12%) 
had a second additional diagnosis of coccidioidomycosis. 
Frequency of hospitalization for coccidioidomycosis was 
3.7 per 100,000 residents per year (Table 1). Kern, Los An-
geles, and San Diego counties had highest total number of 
hospitalizations and together accounted for 47% of all hos-
pitalizations. There were 417 deaths, resulting in a mortal-
ity rate of 2.1 per 1 million California residents annually.
For years for which an RLN was available (1997–
2000), 63% of hospitalizations were initial and 37% were 
repeat. The incidence of initial hospitalization for severe 
coccidioidomycosis was 2.4 per 100,000 residents, and 
8.9% of persons initially hospitalized with coccidioidomy-
cosis died in the initial or a subsequent hospitalization.
Pregnant women were more likely than nonpregnant 
women to be hospitalized with a code for coccidioidomy-
cosis (RR 2.5, 95% confi dence interval [CI] 2.03–3.08). 
Compared with all Californians, RR for hospitalization for 
persons with AIDS was 34.5 (CI 31.0–38.4) and for per-
sons with HIV was 13.9 (CI 12.5–15.5). When only records 
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with RLNs were examined, 24% of persons admitted with 
coccidioidomycosis who had HIV coinfection died during 
hospitalization, compared with 8.2% of persons admitted 
with coccidioidomycosis who did not have HIV coinfec-
tion (p<0.005 by χ2 analysis).
In multivariate Poisson regression that used Califor-
nia Department of Finance population estimates, older age, 
black race/ethnicity, and male sex were associated with in-
creased risk for hospitalization. Native American and His-
panic race/ethnicity was protective for this outcome (see 
reference groups in Table 2). Asian-Pacifi c Islander race/
ethnicity was protective on a statewide level but was a risk 
factor in the 4 counties with the highest incidence.
Logistic regression showed that black persons hos-
pitalized with a diagnosis of coccidioidomycosis had in-
creased risk for rehospitalization (OR 2.08, CI 1.59–2.73) 
compared with white persons, controlling for year, county, 
age, and sex. Controlling for the same confounders, Asian-
Pacifi c Islanders hospitalized with coccidioidomycosis had 
increased risk for meningitis (OR 1.63, CI 1.02–2.63); His-
panic race/ethnicity was protective against meningitis (OR 
0.63, CI 0.48–0.84).
Conclusions
Hospitalizations for coccidioidomycosis are common 
in California, especially in disease-endemic areas. Deaths 
from coccidioidomycosis average ≈70 per year statewide. 
Persons with AIDS have both a very high frequency of hos-
pitalization for coccidioidomycosis and a very high propor-
tion of deaths from the disease. Persons with AIDS in the 
4 counties with the highest frequency of coccidioidomy-
cosis (Kern, Tulare, Kings, and San Luis Obispo) have a 
frequency of hospitalization for coccidioidomycosis that 
approaches 1% per year. This study confi rms several well-
known risk factors for coccidioidomycosis, including black 
race, middle age and older age, and pregnancy (7). We did 
not fi nd evidence supporting previous reports of Hispanic 
and Asian racial/ethnic background as a risk factor for coc-
cidioidomycosis hospitalization statewide (8,9).
This study has several limitations. First, we included all 
hospitalizations that contained any discharge diagnosis of 
coccidioidomycosis; 73% of our included hospitalizations 
coded coccidioidomycosis as principal or fi rst additional di-
agnosis. Among those hospitalizations for which coccidioi-
domycosis was not principal or fi rst additional diagnosis, it 
is unclear whether other principal diagnoses (such as AIDS) 
would have caused hospitalization in the absence of coc-
cidioidomycosis. In this respect, our fi ndings may overesti-
mate the incidence of disease. Second, we have no informa-
tion about persons hospitalized in federal hospitals, which 
could lead to an underestimation of effects of disease or bias 
of results regarding disease distribution. However, because 
only 19 of 570 hospitals licensed in California in 1999 were 
federal, the bias of omitting federal hospitals is likely to be 
small (10). Third, we had information on duplicate hospital-
izations for 1997–2000 only, and some persons either may 
have had a repeat hospitalization subsequently or may have 
been hospitalized for coccidioidomycosis before this period. 
Fourth, we have no data on the subcategory of persons with 
Asian ancestry. The increased risk we found for Asian-Pa-
cifi c Islanders in the 4 counties with highest incidence is not 
consistent with risk statewide, and this might be partly ex-
plained by differential risk by subcategory of race/ethnicity. 
However, differential exposure patterns based on employ-
ment or recreation might also contribute to the discrepancy. 
Further research in this area is needed.
The risk for severe disease and death attributable to 
coccidioidomycosis in California is of a magnitude similar 
to the risk from varicella in the state before the varicella 
vaccine (11,12). Furthermore, a substantially higher risk 
exists for many subgroups, including residents of high-in-
cidence counties, middle-aged and older persons, pregnant 
women, black residents, and those with HIV infection. 
Recent progress in vaccine development has raised the 
Table 1. Hospitalizations for coccidioidomycosis, California, 1997–2002 
Category Total hospitalizations Total person-years (x 106)
Frequency of 
hospitalization*
Frequency of hospitalization 
for coccidioidal meningitis* 
Total 7,457 203.0 3.67 0.657
Year 
 1997 1,269 32.5 3.90 0.706
 1998 1,144 32.9 3.50 0.706
 1999 1,167 33.4 3.5 0.61
 2000 1,100 34.0 3.23 0.62
 2001 1,291 34.7 3.7 0.58
 2002 1,486 35.3 4.2 0.71
Highest incidence counties 
 Kern 1,700 3.97 42.8
 Tulare 479 2.21 21.7
 Kings 133 0.77 17.4
 San Luis Obispo 170 1.48 11.5
*Per 100,000 residents per year. 
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possibility of a way to better control this disease (13). The 
development of new therapeutic and preventive modalities 
could do much for the population at risk and should be con-
sidered a priority for healthcare research. Our data offer a 
good overall estimate of the incidence of severe disease for 
the state, but to assess the success of a new vaccine, further 
studies will need to determine initial hospitalization and 
primary cause of hospitalization with greater specifi city.
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HealthCare Foundation 99-1017 and by the National Institutes of 
Health Grant 1KL2RR024130.
Dr Flaherman is a general pediatrics fellow at the Univer-
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Table 2. Frequency and relative risk for hospitalization for coccidioidomycosis in California and its 4 highest-incidence counties, 1997–
2002*
Population
Frequency of 
hospitalization†
RR for discharge 
diagnosis of 
coccidioidomycosis 
Frequency of 
hospitalization in highest 
incidence counties† 
RR for discharge diagnosis of 
coccidioidomycosis in highest 
incidence counties 
Race‡
 White 3.6 Ref 26.6 Ref
 Hispanic 3.4 0.73 (0.68–0.78) 24.1 0.71 (0.63–0.79) 
 Black 8 2.68 (2.48–2.91) 80.8 2.43 (2.10–2.82) 
 Native American 1.4 0.32 (0.21–0.51) 12.7 0.37 (0.20–0.70) 
 Asian-Pacific Islander 2 0.78 (0.70–0.87) 51 1.62 (1.34–1.97) 
Sex‡ 
 Female 2.3 Ref 36.6 Ref
 Male 5 2.14 (2.03–2.27) 21.9 1.67 (1.53–1.85) 
Age, y‡
<14 0.5 0.12 (0.10–0.14) 3.9 0.12 (0.09–0.15) 
 15–49 3.5 Ref 31.3 Ref
 50–69 7.1 2.13 (2.01–2.26) 57.2 1.83 (1.66–2.03) 
>70 7.3 2.74 (2.54–2.97) 47.0 1.83 (1.58, 2.12) 
Special conditions§ 
 Pregnancy¶ 3.8 2.5 (2.03–3.08) 51.9
 AIDS 127 34.5 (31.0–38.4) 912 31.0 (23.8–40.4) 
 All HIV 51 13.9 (12.5–15.5) 319 10.8 (8.3–14.1) 
*Multivariate results reported for 6,465 cases with no missing data (87%). RR, relative risk; Ref, referent. Values in parentheses are 95% confidence 
intervals.  
†Crude incidence per 100,000 residents in Kern, Tulare, Kings, and San Luis Opispo counties. 
‡RR by multivariate Poisson model controlling for year, county, age, race, and sex. For the years 1997–1999, racial-ethnic categories were White, 
Hispanic, Black, Native American, and Asian-Pacific Islander. For the years 2000–2002, racial-ethnic categories were White, Hispanic, Black, Native 
American, Asian, Pacific Islander, and multirace. The population of multirace represented ≈1% of populations relevant to the study and was not included 
in the analysis. California Department of Finance population estimates from 2000–2002 for Asians and Pacific Islanders were combined into a single 
category, Asian-Pacific Islander, to match coding of the Office of Statewide Health Planning and Development database. All Hispanics in the Department 
of Finance data were assumed to be of white race. 
§Bivariate relative risk. 
¶To estimate a denominator for the pregnant population, we estimated the total person-years of pregnancy for each county in California in the following 
manner. The total number of live births was multiplied by 0.75 (to approximate 9 mo of pregnancy) and added to the total number of fetal deaths, 
multiplied by 0.56 (to estimate a gestation of 30 weeks). This sum was finally added to the total number of abortions, multiplied by 0.19 (to estimate a 
gestation of 10 weeks). Estimates of live births and fetal deaths were obtained from the Center for Health Statistics Birth Rate Tables (5). Annual number 
of abortions was estimated from federal abortion surveillance data from 1997 (6).
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